Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,General Medicine
Link
http://www.nature.com/articles/ncponc1150.pdf
Reference94 articles.
1. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438: 932–936
2. Ferrara N and Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438: 967–974
3. Kerbel R and Folkman J (2002) Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2: 727–739
4. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25: 581–611
5. Ferrara N et al. (2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 333: 328–335
Cited by 135 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies;Stem Cells International;2024-01
2. Advances in Predictive Biomarkers for Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer;Cancer Control;2024-01
3. Glucagon Enhances Chemotherapy Efficacy By Inhibition of Tumor Vessels in Colorectal Cancer;Advanced Science;2023-12-10
4. Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy;Advanced Science;2022-11-27
5. Tumor Angiogenesis;Holland‐Frei Cancer Medicine;2022-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3